Abstract

Alteration of normal ploidy (aneuploidy) can have a number of opposing effects, such as unbalancing protein abundances and inhibiting cell growth but also accelerating genetic diversification and rapid adaptation. The interplay of these detrimental and beneficial effects remains puzzling. Here, to understand how cells develop tolerance to aneuploidy, we subject disomic (i.e. with an extra chromosome copy) strains of yeast to long-term experimental evolution under strong selection, by forcing disomy maintenance and daily population dilution. We characterize mutations, karyotype alterations and gene expression changes, and dissect the associated molecular strategies. Cells with different extra chromosomes accumulated mutations at distinct rates and displayed diverse adaptive events. They tended to evolve towards normal ploidy through chromosomal DNA loss and gene expression changes. We identify genes with recurrent mutations and altered expression in multiple lines, revealing a variant that improves growth under genotoxic stresses. These findings support rapid evolvability of disomic strains that can be used to characterize fitness effects of mutations under different stress conditions.

Aneuploidy (abnormal chromosome number) can enable rapid adaptation to stress conditions, but it also entails fitness costs from gene imbalance. Here, the authors experimentally evolve yeast while forcing maintenance of aneuploidy to identify the mechanisms that promote tolerance of aneuploidy.

Details

Title
Molecular signatures of aneuploidy-driven adaptive evolution
Author
Kaya Alaattin 1   VIAFID ORCID Logo  ; Mariotti, Marco 2   VIAFID ORCID Logo  ; Tyshkovskiy Alexander 3   VIAFID ORCID Logo  ; Zhou, Xuming 2 ; Hulke, Michelle L 4 ; Ma Siming 2 ; Gerashchenko, Maxim V 2   VIAFID ORCID Logo  ; Koren Amnon 4 ; Gladyshev, Vadim N 2 

 Brigham and Women’s Hospital and Harvard Medical School, Division of Genetics, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294); Virginia Commonwealth University, Department of Biology, Richmond, USA (GRID:grid.224260.0) (ISNI:0000 0004 0458 8737) 
 Brigham and Women’s Hospital and Harvard Medical School, Division of Genetics, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294) 
 Brigham and Women’s Hospital and Harvard Medical School, Division of Genetics, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294); Skolkovo Institute of Science and Technology, Center for Data-Intensive Biomedicine and Biotechnology, Moscow, Russia (GRID:grid.454320.4) (ISNI:0000 0004 0555 3608); Moscow State University, Belozersky Institute of Physico-Chemical Biology, Moscow, Russia (GRID:grid.14476.30) (ISNI:0000 0001 2342 9668) 
 Cornell University Department of Molecular Biology and Genetics, Ithaca, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2348784858
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.